These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32879207)

  • 1. Telmisartan Exacerbates Cisplatin-Induced Nephrotoxicity in a Mouse Model.
    Hosoda A; Matsumoto Y; Toriyama Y; Tsuji T; Yoshida Y; Masamichi S; Kohno T
    Biol Pharm Bull; 2020; 43(9):1331-1337. PubMed ID: 32879207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-angiotensin system inhibitors combined with cisplatin exacerbate cisplatin-induced nephrotoxicity in mice.
    Tsuji T; Hosoda A; Toriyama Y; Yoshida Y; Kohno T
    Transl Oncol; 2022 Apr; 18():101369. PubMed ID: 35182957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of the angiotensin II receptor blocker losartan on cisplatin-induced kidney injury.
    Saleh S; Ain-Shoka AA; El-Demerdash E; Khalef MM
    Chemotherapy; 2009; 55(6):399-406. PubMed ID: 19955745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of relaxin against cisplatin-induced nephrotoxicity in rats.
    Yoshida T; Kumagai H; Kohsaka T; Ikegaya N
    Nephron Exp Nephrol; 2014; 128(1-2):9-20. PubMed ID: 25403022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudoginsengenin DQ Exhibits Therapeutic Effects in Cisplatin-Induced Acute Kidney Injury via Sirt1/NF-κB and Caspase Signaling Pathway without Compromising Its Antitumor Activity in Mice.
    Qi Z; Li Z; Li W; Liu Y; Wang C; Lin H; Liu J; Li P
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30469321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of gemcitabine on cisplatin-induced nephrotoxicity in rats: schedule-dependent study.
    Saad SY; Najjar TA; Noreddin AM; Al-Rikabi AC
    Pharmacol Res; 2001 Feb; 43(2):193-8. PubMed ID: 11243722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine.
    Saad SY; Najjar TA; Daba MH; Al-Rikabi AC
    Chemotherapy; 2002; 48(6):309-15. PubMed ID: 12673106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of royal jelly and green tea extracts effect against cisplatin-induced nephrotoxicity in mice: a comparative study.
    Yapar K; Cavuşoğlu K; Oruç E; Yalçin E
    J Med Food; 2009 Oct; 12(5):1136-42. PubMed ID: 19857080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the renin-angiotensin system in cisplatin nephrotoxicity.
    Deegan PM; Nolan C; Ryan MP; Basinger MA; Jones MM; Hande KR
    Ren Fail; 1995 Nov; 17(6):665-74. PubMed ID: 8771239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity after intravenous infusions of cisplatin to cancer patients.
    Nagai N; Kinoshita M; Ogata H; Tsujino D; Wada Y; Someya K; Ohno T; Masuhara K; Tanaka Y; Kato K; Nagai H; Yokoyama A; Kurita Y
    Cancer Chemother Pharmacol; 1996; 39(1-2):131-7. PubMed ID: 8995510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a cisplatin-chondroitin sulfate A complex in reducing the nephrotoxicity of cisplatin.
    Zhang JS; Imai T; Otagiri M
    Arch Toxicol; 2000 Aug; 74(6):300-7. PubMed ID: 11005675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of PARP activation by enalapril is crucial for its renoprotective effect in cisplatin-induced nephrotoxicity in rats.
    Rani N; Bharti S; Tomar A; Dinda AK; Arya DS; Bhatia J
    Free Radic Res; 2016; 50(11):1226-1236. PubMed ID: 27571604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway.
    Elsayed AM; Abdelghany TM; Akool el-S; Abdel-Aziz AA; Abdel-Bakky MS
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Mar; 389(3):327-37. PubMed ID: 26659823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in Cisplatin Pharmacokinetics and Its Acute/Sub-chronic Kidney Injury over Multiple Cycles of Cisplatin Treatment in Rats.
    Okada A; Fukushima K; Fujita M; Nakanishi M; Hamori M; Nishimura A; Shibata N; Sugioka N
    Biol Pharm Bull; 2017; 40(11):1948-1955. PubMed ID: 29093343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower blood pressure and risk of cisplatin nephrotoxicity: a retrospective cohort study.
    Komaki K; Kusaba T; Tanaka M; Kado H; Shiotsu Y; Matsui M; Shiozaki A; Nakano H; Ishikawa T; Fujiwara H; Konishi H; Itoh Y; Matoba S; Tamagaki K
    BMC Cancer; 2017 Feb; 17(1):144. PubMed ID: 28219368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin pharmacokinetics and its nephrotoxicity in diabetic rabbits.
    Najjar TA; Saad SY
    Chemotherapy; 2001; 47(2):128-35. PubMed ID: 11173815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of nephrotoxicity of cisplatin by repeated oral administration of ebselen in rats.
    Yoshida M; Iizuka K; Terada A; Hara M; Nishijima H; Akinori ; Shimada ; Nakada K; Satoh Y; Akama Y
    Tohoku J Exp Med; 2000 Aug; 191(4):209-20. PubMed ID: 11038013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnosic acid attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity.
    Sahu BD; Rentam KK; Putcha UK; Kuncha M; Vegi GM; Sistla R
    Food Chem Toxicol; 2011 Dec; 49(12):3090-7. PubMed ID: 21930180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dabigatran mitigates cisplatin-mediated nephrotoxicity through down regulation of thrombin pathway.
    Ewees MGE; Abdel-Bakky MS; Bayoumi AMA; Abo-Saif AA; Altowayan WM; Alharbi KS; Messiha BAS
    J Adv Res; 2021 Jul; 31():127-136. PubMed ID: 34194837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivo.
    Terada Y; Inoue K; Matsumoto T; Ishihara M; Hamada K; Shimamura Y; Ogata K; Inoue K; Taniguchi Y; Horino T; Karashima T; Tamura K; Fukuhara H; Fujimoto S; Tsuda M; Shuin T
    PLoS One; 2013; 8(12):e80850. PubMed ID: 24324635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.